MEDIFAST INC (NYSE:MED) updated its third quarter earnings guidance on Tuesday. The company provided EPS guidance of $0.48-$0.51 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.53. The company issued revenue guidance of $72-$75 million, compared to the consensus revenue estimate of $73.31 million.MEDIFAST INC also updated its FY17 guidance to $2.05-$2.15 EPS.

Separately, Sidoti cut shares of MEDIFAST INC from a buy rating to a neutral rating in a research note on Tuesday, May 2nd.

Shares of MEDIFAST INC (NYSE:MED) traded up 4.86% during midday trading on Tuesday, hitting $44.21. 135,683 shares of the stock were exchanged. The firm has a 50-day moving average of $41.69 and a 200-day moving average of $43.12. The company has a market capitalization of $527.29 million, a P/E ratio of 26.96 and a beta of 0.48. MEDIFAST INC has a 1-year low of $34.76 and a 1-year high of $47.35.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 9th. Investors of record on Friday, June 23rd will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 2.90%. The ex-dividend date of this dividend is Wednesday, June 21st. MEDIFAST INC’s dividend payout ratio (DPR) is presently 77.58%.

ILLEGAL ACTIVITY NOTICE: This piece was first reported by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at

MEDIFAST INC Company Profile

Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.

Receive News & Ratings for MEDIFAST INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related companies with's FREE daily email newsletter.